Keystone Investors Pte LTD Viking Therapeutics, Inc. Transaction History
Keystone Investors Pte LTD
- $1.17 Billion
- Q2 2024
A detailed history of Keystone Investors Pte LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Keystone Investors Pte LTD holds 91,948 shares of VKTX stock, worth $5.89 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
91,948
Previous 111,597
17.61%
Holding current value
$5.89 Million
Previous $9.15 Million
46.73%
% of portfolio
0.42%
Previous 0.8%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
443Shares Held
63.4MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$647 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$386 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$328 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$144 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$119 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.92B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...